Acurx Pharmaceuticals (ACXP) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Acurx Pharmaceuticals (ACXP) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Acurx Pharmaceuticals

· ACXP

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

7.255 M

-3.45%

General

Market Cap: $7.26M
Enterprise Value: -$5.24M
Shares Outstanding: 4,300,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -68.33%
ROE: -124.74%
ROIC: -94.08%
Current Ratio: 3.88
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.66
EV/EBITDA: 0.69

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $7.67M
Operating Income: -$7.67M
Net Profit: -$7.51M

Balance Sheet

Cash and Equivalents: $10.66M
Working Capital: $8.15M
Total Assets: $10.98M
Net Debt: -$10.66M
Total Liabilities: $2.83M
Total Equity: $8.15M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$6.18M
Cash Flow from Investing: —
Cash Flow from Financing: $10.78M
Free Cash Flow: -$6.18M
Capital Expenditures: -$2